Shahrokh Shabahang - 25 May 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
CHIEF INNOVATION OFFICER, Director
Signature
/s/ Shahrokh Shabahang
Issuer symbol
ADTX
Transactions as of
25 May 2021
Net transactions value
+$1,498
Form type
4
Filing time
28 May 2021, 18:49:46 UTC
Next filing
02 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Purchase $670 +279 +0.03% $2.40* 1,015,285 25 May 2021 By son F1
transaction ADTX Common Stock Purchase $328 +138 +0.01% $2.38* 1,015,423 25 May 2021 By son F1
transaction ADTX Common Stock Purchase $500 +185 +0.02% $2.70* 1,015,608 27 May 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 Fractional amounts have been rounded to the nearest whole number.